TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11226098

Group type: EXPERIMENTAL
Intervention: FBM: fentanyl (25 microg) and bupivacaine (2.5 mg) plus morphine (150 microg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: FB: fentanyl (25 microg) and bupivacaine (2.5 mg)
Number of subjects: 95
Study: 11154952

Group type: EXPERIMENTAL
Intervention: CHO solution containing 1.7 g CHO/kg(body weight)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isocaloric solution containing 1.2 g CHO/kg(body weight) plus 0.5 g protein/kg(body weight) (including 5 g arginine)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Zero-caloric placebo diet
Number of subjects: 8
Study: 8989740

Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.58 g/kg per day)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Usual-protein diet (1.3 g/kg per day)
Number of subjects: 585
Study: 1637601

Group type: EXPERIMENTAL
Intervention: Extradural analgesia initiated 40 min before surgical incision
Number of subjects: 32

Group type: COMPARATOR
Intervention: Extradural analgesia initiated at closure of the surgical wound
Number of subjects: 32
Study: 6721526

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 6
Study: 31685813

Group type: EXPERIMENTAL
Intervention: Topiramate (50-200 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 62
Study: 29174422

Group type: EXPERIMENTAL
Intervention: Magnesium screw
Number of subjects: 26

Group type: COMPARATOR
Intervention: Titanium screw
Number of subjects: 26
Study: 26733011

Group type: EXPERIMENTAL
Intervention: PsychoEducation, Paced Respiration, and Relaxation (PEPRR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 24
Study: 25227174

Group type: EXPERIMENTAL
Intervention: Patient satisfaction score feedback with usual multisource feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual multisource feedback alone
Number of subjects: 0
Study: 22150634

Group type: EXPERIMENTAL
Intervention: Combined parent and teacher manual-based group training programme (modified version of Barkley's programme)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 129
Study: 20456211

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 1172

Group type: COMPARATOR
Intervention: Glipizide 5 mg/day (up-titrated to 20 mg/day)
Number of subjects: 1172
Study: 17429836

Group type: EXPERIMENTAL
Intervention: Induction therapy with imatinib (Ind(IM))
Number of subjects: 55

Group type: COMPARATOR
Intervention: Induction therapy with multiagent, age-adapted chemotherapy (Ind(chemo))
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ind(chemo)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combined imatinib and chemotherapy consolidation
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 55
Study: 16338283

Group type: EXPERIMENTAL
Intervention: Sitagliptin (1.5-600 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12033714

Group type: EXPERIMENTAL
Intervention: Asperger syndrome
Number of subjects: 150

Group type: COMPARATOR
Intervention: Autistic disorder
Number of subjects: 150

Group type: COMPARATOR
Intervention: ADHD
Number of subjects: 150
Study: 9807990

Group type: EXPERIMENTAL
Intervention: MDMA users
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 7625583

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 2778359

Group type: EXPERIMENTAL
Intervention: Biofeedback training sessions and equipment during labor
Number of subjects: 40
Study: 31483769

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (non-TXA)
Number of subjects: 95
Study: 27811278

Group type: COMPARATOR
Intervention: Oestradiol (oestrogen)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Testosterone/Oestradiol combination
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25361769

Group type: EXPERIMENTAL
Intervention: γ-Tocopherol (γ-T) rich mixture of tocopherols (γ-TmT), 500 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT) with γ-TmT
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nicotine replacement therapy (NRT) alone (placebo)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: γ-TmT
Number of subjects: 23

Group type: COMPARATOR
Intervention: NRT-assisted smoking abstinence alone
Number of subjects: 23
Study: 23305914

Group type: EXPERIMENTAL
Intervention: Nurse talk duration
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Nurse characteristics
Number of subjects: 89
Study: 22122028

Group type: EXPERIMENTAL
Intervention: Presence of co-victimization
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Salience of inclusive social identity
Number of subjects: 181

Group type: COMPARATOR
Intervention: Co-victimization without inclusive social identity
Number of subjects: 181
Study: 19786675

Group type: EXPERIMENTAL
Intervention: Geriatric Home Hospitalization Service (GHHS)
Number of subjects: 101

Group type: COMPARATOR
Intervention: General medical ward
Number of subjects: 101
Study: 16413892

Group type: EXPERIMENTAL
Intervention: Midazolam 0.03 mg/kg, remifentanil: propofol (1:500) at 40 microg/kg/min
Number of subjects: 47

Group type: COMPARATOR
Intervention: Midazolam 0.03 mg/kg, fentanyl 1 microg/kg, propofol at 140 microg/kg/min
Number of subjects: 47
Study: 15531170

Group type: EXPERIMENTAL
Intervention: Unilateral imposed equinus constraint
Number of subjects: 12
Study: 12380231

Group type: EXPERIMENTAL
Intervention: Fermi-type rabies vaccine (0.25 ml) administered to groups 2-5 of mice for 14 consecutive days.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fermi-type rabies vaccine for human PEP (prescribed dosage).
Number of subjects: 17

Group type: COMPARATOR
Intervention: Phenolized saline (0.25 ml) administered to group 1 of mice for 14 consecutive days.
Number of subjects: 17
Study: 9251974

Group type: EXPERIMENTAL
Intervention: 24% sucrose solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.25% quinine hydrochloride solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Corn oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water
Number of subjects: 60
Study: 8119426

Group type: EXPERIMENTAL
Intervention: Subconjunctival bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical amethocaine
Number of subjects: 40
Study: 3670697

Group type: EXPERIMENTAL
Intervention: Motor Activation Therapy (MAT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Buflomedil + Motor Activation Therapy (MAT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 31159639

Group type: EXPERIMENTAL
Intervention: Distributed practice
Number of subjects: 50

Group type: COMPARATOR
Intervention: Massed practice
Number of subjects: 50
Study: 29338476

Group type: EXPERIMENTAL
Intervention: Carboxytherapy (subcutaneous infusion)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mesolipolysis using phosphatidylcholine (PPC)
Number of subjects: 48
Study: 28449368

Group type: EXPERIMENTAL
Intervention: omarigliptin 25 mg once weekly
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: sitagliptin 50 mg once daily
Number of subjects: 414

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 414
Study: 26612980

Group type: EXPERIMENTAL
Intervention: SHRED (multi-ingredient supplement)
Number of subjects: 12

Group type: COMPARATOR
Intervention: PL (placebo)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SHRED
Number of subjects: 12
Study: 23612106

Group type: EXPERIMENTAL
Intervention: 27.6 mg of iron (ferrous fumarate enriched with 13% haem iron) daily for 12 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: 100 mg ferrosulphate daily for 12 weeks
Number of subjects: 76
Study: 21225090

Group type: EXPERIMENTAL
Intervention: NOMAC/E2 (2.5 mg/1.5 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: LNG/EE (100 μg/20 μg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: NOMAC/E2
Number of subjects: 90

Group type: COMPARATOR
Intervention: LNG/EE
Number of subjects: 90
Study: 18394916

Group type: EXPERIMENTAL
Intervention: Postoperative concomitant chemo-radiation consisting of 60Gy external-beam radiotherapy and temozolomide (TMZ) administered concomitantly (75mg/m² daily) and after radiotherapy (150-200mg/m², for 5 days every 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrosourea-based chemotherapy or temozolomide re-challenge at time of recurrence/progression
Number of subjects: 0
Study: 16460667

Group type: EXPERIMENTAL
Intervention: Positive helping alliance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment expectancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High motivation to change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive alliance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: None of the predictors
Number of subjects: 0
Study: 12545288

Group type: EXPERIMENTAL
Intervention: Group 2 (over 60 years)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Group 1 (under 60 years)
Number of subjects: 69
Study: 10826576

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 62
Study: 8844442

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily for 15 days (morning administration)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily for 15 days (evening administration)
Number of subjects: 16
Study: 1321198

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure measurement
Number of subjects: 87

Group type: COMPARATOR
Intervention: Clinic blood pressure measurement
Number of subjects: 87

Group type: COMPARATOR
Intervention: Clinic systolic pressure
Number of subjects: 87

Group type: COMPARATOR
Intervention: Clinic diastolic pressure
Number of subjects: 87

Group type: COMPARATOR
Intervention: Amplitude of the diurnal profile
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Mean 24-h pressures
Number of subjects: 87
Study: 6588486

Group type: EXPERIMENTAL
Intervention: Metronidazole (1500 mg infused during 50 minutes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tinidazole (1500 mg infused during 50 minutes)
Number of subjects: 0
Study: 29533000

Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg until disease progression or unacceptable toxicity)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Rituximab (up to six cycles)
Number of subjects: 160
Study: 27716864

Group type: EXPERIMENTAL
Intervention: 6.6% CHO beverage
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-CHO control
Number of subjects: 16
Study: 23661492

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intra-articular betamethasone
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no alendronate)
Number of subjects: 160
Study: 24423369

Group type: EXPERIMENTAL
Intervention: Bone marrow cell (BMC) therapy in non-smokers
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Bone marrow cell (BMC) therapy in smokers
Number of subjects: 101

Group type: COMPARATOR
Intervention: Active smoking
Number of subjects: 101
Study: 20556924

Group type: EXPERIMENTAL
Intervention: Standard formula
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formula enriched with n-3 fatty acids
Number of subjects: 30
Study: 18824999

Group type: EXPERIMENTAL
Intervention: Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk study
Number of subjects: 11218

Group type: EXPERIMENTAL
Intervention: Dexanabinol study
Number of subjects: 11218
Study: 16796710

Group type: EXPERIMENTAL
Intervention: Nadroparin 2850 IU (0.3 mL)
Number of subjects: 1288

Group type: COMPARATOR
Intervention: Enoxaparin 4000 IU (40 mg)
Number of subjects: 1288
Study: 14632678

Group type: EXPERIMENTAL
Intervention: PCM (pantoprazole 40 mg, clarithromycin 500 mg, metronidazole 500 mg)
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: PCA (pantoprazole, clarithromycin, amoxicillin 1000 mg)
Number of subjects: 1016

Group type: COMPARATOR
Intervention: All regimens tested
Number of subjects: 1016
Study: 10863714

Group type: EXPERIMENTAL
Intervention: Pulsed shortwave diathermy (PSWD) at a constant setting of pulse duration (400 microseconds) and pulse power (190 W) with PRR increased from 26 Hz to 400 Hz in 10 increments, applied for two minutes.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group exposed to PSWD at its lowest settings (pulse power = 5 W; pulse duration = 65 microseconds and PRR = 26 Hz).
Number of subjects: 30
Study: 9197949

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 6
Study: 1283180

Group type: EXPERIMENTAL
Intervention: Acediprol
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ethacizine
Number of subjects: 51
Study: 3815457

Group type: EXPERIMENTAL
Intervention: Pinaverium bromide (15 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30149614

Group type: EXPERIMENTAL
Intervention: Parental opinions on clinical dietary trials
Number of subjects: 17
Study: 26204567

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Exposure Therapy (ET)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 70
Study: 24259558

Group type: EXPERIMENTAL
Intervention: High magnesium intake (highest tertile)
Number of subjects: 7216

Group type: COMPARATOR
Intervention: Control diet (advice on a low-fat diet)
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts or olive oil
Number of subjects: 7216
Study: 21414133

Group type: EXPERIMENTAL
Intervention: Flapless implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional implants (flap-group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (males vs females)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Flapless procedure
Number of subjects: 40
Study: 21381321

Group type: EXPERIMENTAL
Intervention: Moderately intensive physical exercises during a long period
Number of subjects: 0
Study: 17697901

Group type: EXPERIMENTAL
Intervention: Ebastine fast-dissolving tablet 20 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Desloratadine capsule 5 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 15889392

Group type: EXPERIMENTAL
Intervention: Hot-deck (HD) multiple imputation using predictive mean matching for item non-response and approximate Bayesian bootstrap for unit non-response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivariate normal (MVN) model using PROC MI in SAS software V8.2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Last observation carried forward (LOCF) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Available-case (AC) analysis
Number of subjects: 0
Study: 10675060

Group type: EXPERIMENTAL
Intervention: Continuous or dashed edge lines on experimental roads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Driving test on experimental roads
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental roads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unlined control road
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edge-lined roads
Number of subjects: 0
Study: 9282970

Group type: EXPERIMENTAL
Intervention: Decorin expression in healing gastric ulcers
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Biglycan expression in healing gastric ulcers
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal gastric tissue
Number of subjects: 18
Study: 8117902

Group type: EXPERIMENTAL
Intervention: Mantel-Haenszel test for grouped failure time data (MHF test)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing the number of subintervals in the MHF test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choice of frequency and actual times of measurement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Power under exponential failure and censoring models
Number of subjects: 0
Study: 3578948

Group type: EXPERIMENTAL
Intervention: Fresh gas flow of 482.5 +/- 186.6 ml X min‐1 (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fresh gas flow of 2000 ml X min‐1 (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fresh gas flow adjusted to 7145 +/- 986 ml X min‐1 (Group C)
Number of subjects: 60
Study: 31188081

Group type: EXPERIMENTAL
Intervention: Lower vitamin B6 intake (tertile 1) in total population
Number of subjects: 3362

Group type: EXPERIMENTAL
Intervention: Lower vitamin B6 intake (tertile 1) in women
Number of subjects: 3362
Study: 29068904

Group type: EXPERIMENTAL
Intervention: Palliative Care Teams (PCTeams)
Number of subjects: 5830

Group type: COMPARATOR
Intervention: Control
Number of subjects: 5830

Group type: COMPARATOR
Intervention: Nonrandomized Control
Number of subjects: 5830
Study: 26824527

Group type: COMPARATOR
Intervention: 0.2 mg tamsulosin alone
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 0.2 mg tamsulosin with 0.5 mg dutasteride daily for 12 months
Number of subjects: 118
Study: 23275019

Group type: EXPERIMENTAL
Intervention: Intravenously administered golimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21641522

Group type: EXPERIMENTAL
Intervention: Light therapy at 10,000 lux
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual standard of care and light therapy at 50 lux
Number of subjects: 0
Study: 18047629

Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.0 mL (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.2 mL (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.4 mL (Group C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 2.5% CP 1.6 mL (Group D)
Number of subjects: 120
Study: 17195601

Group type: EXPERIMENTAL
Intervention: Neuroscience strategies applied in psychological treatment research
Number of subjects: 0
Study: 14998900

Group type: EXPERIMENTAL
Intervention: Exposure therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Skills training
Number of subjects: 52
Study: 11938860

Group type: EXPERIMENTAL
Intervention: Yinchen Dandao decoction (YCDDD) administered orally for 1 week starting 3 days after operation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 60
Study: 9080642

Group type: EXPERIMENTAL
Intervention: Deslorelin (2.2 mg, subcutaneously as a short-term implant)
Number of subjects: 272
Study: 8401637

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy following radical cystectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy following cystectomy or aggressive TUR
Number of subjects: 0
Study: 3426824

Group type: EXPERIMENTAL
Intervention: Phosphocreatine (PC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no phosphocreatine)
Number of subjects: 60
Study: 29401241

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF) 60-64.8 Gy (25-27 fractions)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard fractionation (SF) 66-70 Gy (33-35 fractions)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Standard fractionation (SF)
Number of subjects: 370
Study: 25257752

Group type: EXPERIMENTAL
Intervention: Low-intensity RE at 20% of 1RM (LI)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-intensity RE at 20% of 1RM combined with partial blood flow restriction (LI+BFR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-intensity RE at 80% of 1RM (HI)
Number of subjects: 24
Study: 25346595

Group type: EXPERIMENTAL
Intervention: Color-coded BP booklet for daily home BP measurement
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard BP booklet
Number of subjects: 121
Study: 23744819

Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg kg(‐1) i.v.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 50
Study: 20593151

Group type: EXPERIMENTAL
Intervention: 200 IU daily vitamin D
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 400 IU daily vitamin D
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 50,000 IU bolus every two months
Number of subjects: 120
Study: 19128711

Group type: EXPERIMENTAL
Intervention: Rapid Rhino (RR) nasal pack
Number of subjects: 51

Group type: COMPARATOR
Intervention: Merocel nasal pack
Number of subjects: 51
Study: 21169165

Group type: EXPERIMENTAL
Intervention: Internet version of the Beck Depression Inventory (BDI-II)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Paper version of the Beck Depression Inventory (BDI-II)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Internet version of the Montgomery-Åsberg Depression Rating Scale-Self-rated (MADRS-S)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Paper version of the Montgomery-Åsberg Depression Rating Scale-Self-rated (MADRS-S)
Number of subjects: 87
Study: 16238764

Group type: EXPERIMENTAL
Intervention: Feeding skills training programme (3 hours of in-service classes and 1 hour of hands-on training)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Feeding skills training programme
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 67
Study: 11964551

Group type: EXPERIMENTAL
Intervention: Indinavir (1200 mg orally)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 9485556

Group type: EXPERIMENTAL
Intervention: Phenytoin (third dose)
Number of subjects: 18
Study: 7803948

Group type: EXPERIMENTAL
Intervention: Vinorelbine combined with cisplatin
Number of subjects: 600

Group type: COMPARATOR
Intervention: Vinorelbine as second-line chemotherapy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Vinorelbine plus doxorubicin
Number of subjects: 600

Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Vinorelbine (oral dosage form)
Number of subjects: 600